Mirtazapine for depression in inflammatory bowel disease
Treatments studied
Part of Digestive system, Mental health clinical trials.
This trial tests whether the antidepressant mirtazapine can help people with Crohn's disease or ulcerative colitis who also have moderate or severe depression. If you are at least 18 and your IBD treatment is stable, this study could see if this medication improves your mood without interfering with your gut condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease or ulcerative colitis diagnosed by your doctor.
- You have moderate or severe depression that is not part of a psychotic disorder.
- You are 18 years old or older.
- If you could become pregnant, you agree to use birth control and have a negative pregnancy test before starting.
- Your IBD treatment is not expected to change in the next 12 weeks.
- You are not currently taking mirtazapine, mianserin, trazodone, or an MAOI antidepressant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how anxiety and depression impact inflammatory bowel disease (IBD) in people taking infliximab or vedolizumab infusions. It aims to improve understanding and treatment of both mental health and IBD together.
This study tests whether two anti-inflammatory drugs, celecoxib and minocycline, can help treat depression. You may join if you have moderate to severe depression and are not at high risk for certain medical conditions or drug interactions.
This trial tests a medication called tocilizumab, which targets inflammation, to see if it can improve symptoms of major depression in people with signs of inflammation. You may be eligible if you have depression with a high monocyte count and significant loss of interest or pleasure.
This study tests whether doctors can choose the best add-on immune-related treatment for people with major depressive disorder by using inflammation blood tests. It’s meant for people whose depression has not improved enough with their current antidepressant.
This study tests whether duloxetine, a medication used for pain and mood, can help people with inflammatory bowel disease (IBD) who are also dealing with high stress, disability, or gut-related anxiety.
This trial looks at how brain circuits work in people with inflammatory bowel disease (IBD) who also have depression. It may help find new ways to treat both conditions together.
Hear when a new Major Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.